Our Progressive Approach to creating a new standard of care

keystone-heart-head
meet-keystone-heart-btm-line

Keystone Heart, a Venus Medtech company

Our Progressive Approach to creating a new standard of care

Clinic Studies

Clinic Studies

Clinical Studies

 

Resurs Interviews

Resurs Interviews

Abstracts and Manuscripts

 

Patient Information

Patient Information

Physician Presentations

 

    

Resource Center

    

Latest News

Your Source for the
latest news from
Keystone Heart
Keystone Heart, A Venus Medtech Company, Announces First Commercial Case Performed Worldwide with the TriGUARD 3™ Cerebral Embolic Protection Device

Keystone Heart, A Venus Medtech Company, Announces First Commercial Case Performed Worldwide with the TriGUARD 3™ Cerebral Embolic Protection Device

July 29, 2020
TAMPA, Fla., July 29, 2020 /PRNewswire/ -- Keystone Heart, LTD., a medical device innovator driven to redefine the standard of structural heart care,
Read MoreView All
Keystone Heart, A Venus Medtech Company, Acquires 510 Kardiac Devices, Inc.

Keystone Heart, A Venus Medtech Company, Acquires 510 Kardiac Devices, Inc.

June 16, 2020
TAMPA, Fla., June 16, 2020 /PRNewswire/ -- Keystone Heart, LTD., a medical device innovator driven to redefine the standard of structural heart care,
Read MoreView All
Venus Medtech Announces Agreement to Acquire Keystone Heart, LTD

Venus Medtech Announces Agreement to Acquire Keystone Heart, LTD

January 09, 2019
Merger Establishes US and EMEA Presence for the Preeminent Chinese Structural Heart Company HANGZHOU, China and CAESAREA, Israel and TAMPA, Florida
Read MoreView All
Current Cerebral Embolic Protection Landscape

Current Cerebral Embolic Protection Landscape

December 03, 2018
Keystone Heart TriGUARD Data Review Jeffrey Moses Conclusions: Overt and Covert stroke are significant complications of TAVR which may be o
Read MoreView All
REFLECT Clinical Update with TriGUARD3 Cerebral Embolic Protection Device

REFLECT Clinical Update with TriGUARD3 Cerebral Embolic Protection Device

December 03, 2018
Tamim Nazif Conclusions: TriGUARD 3™ offers complete 3 vessel cerebral embolic protection for TAVR Specific design improvements optimize
Read MoreView All